Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: Heart failure causes severe lung disease

Hypertension

Volumn 59, Issue 6, 2012, Pages 1170-1178

  Chen, Yingjie ^a   Guo, Haipeng ^a,b   Xu, Dachun ^a,c   Xu, Xin ^a   Wang, Huan ^a   Hu, Xinli ^a   Lu, Zhongbing ^a   Kwak, Dongmin ^a   Xu, Yawei ^c   Gunther, Roland ^d   Huo, Yuqing ^a   Weir, E Kenneth ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SHANDONG UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Pulmonary hypertension; Pulmonary vascular morphology; Transverse aortic constriction

Indexed keywords

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CELL INFILTRATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; INFLAMMATION; LEUKOCYTE; LUNG BLOOD VESSEL; LUNG FIBROSIS; LUNG WEIGHT; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFOUND LUNG REMODELING; PULMONARY HYPERTENSION; VASCULAR FIBROSIS;

ANIMALS; ANOXIA; AORTA; BLOTTING, WESTERN; COLLAGEN; CONSTRICTION, PATHOLOGIC; FIBROSIS; HEART FAILURE; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; LEUKOCYTES; LUNG; LUNG DISEASES; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; PULMONARY EDEMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR DYSFUNCTION, LEFT; WATER;

EID: 84861526249     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.186072     Document Type: Article

References (17)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S43-S54.
2. Cournand A, Bloomfield RA, Lauson HD. Double lumen catheter for intravenous and intracardiac blood sampling and pressure recording. Proc Soc Exp Biol Med. 1945;60:73-75.
3. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219-1263.
4. Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, Redfield MM, Robbins IM, Souza R, Torbicki A, McGoon M. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S85-S96.
5. Grigioni F, Potena L, Galiè N, Fallani F, Bigliardi M, Coccolo F, Magnani G, Manes A, Barbieri A, Fucili A, Magelli C, Branzi A. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant. 2006;25: 1241-1246.
6. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37: 183-188.
7. Lu Z, Fassett J, Xu X, Hu X, Zhu G, French J, Zhang P, Schnermann J, Bache RJ, Chen Y. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation. 2008;118:1713-1721.
8. Lu Z, Xu X, Hu X, Lee S, Traverse JH, Zhu G, Fassett J, Tao Y, Zhang P, dos Remedios C, Pritzker M, Hall JL, Garry DJ, Chen Y. Oxidative stress regulates left ventricular PDE5 expression in the failing heart. Circulation. 2010;121:1474-1483.
9. Xu D, Guo H, Xu X, Lu Z, Fassett J, Hu X, Xu Y, Tang Q, Hu D, Somani A, Geurts AM, Ostertag E, Bache RJ, Weir EK, Chen Y. Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase. Hypertension. 2011;58:303-309.
10. Lu Z, Xu X, Hu X, Zhu G, Zhang P, van Deel ED, French JP, Fassett JT, Oury TD, Bache RJ, Chen Y. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension. 2008;51:19-25.
11. Urboniene D, Haber I, Fang YH, Thenappan T, Archer SL. Validation of high-resolution echocardiography and magnetic resonance imaging versus high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2010;299:L401-L412.
12. Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, Li J, Huang Y, Zhang P, Zhao B, Chen Y. PGC-1regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal. 2010;13:1011-1022.
13. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med. 2005;11:214-222.
14. Wang H, Zhang W, Tang R, Hebbel RP, Kowalska MA, Zhang C, Marth JD, Fukuda M, Zhu C, Huo Y. Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoEdeficient mice. Arterioscler Thromb Vasc Biol. 2009;29:1053-1059.
15. Wagenvoort C, Wagenvoort N. Pathology of Pulmonary Hypertension. Pulmonary Venous Hypertension. New York, NY: John Wiley & Sons; 1977:177-216.
16. Wagenvoort CA Lung biopsies and pulmonary vascular disease. In: Pulmonary Hypertension. Weir EK, Reeves JT, eds. New York, NY: Futura Publishing Co; 1984.
17. Haworth SG, Hall SM, Panja M. Peripheral pulmonary vascular and airway abnormalities in adolescents with rheumatic mitral stenosis. Int J Cardiol. 1988;18:405-416.